A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.

At every level of leadership, Premier’s experts are driving healthcare forward.

Leadership
Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.  

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.  

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Data, inquiry and intervention services.

Our most recent insights, articles and more, all in one place.  

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Pharmacy

    Staying on Top of Accreditation & Regulatory Surveys

Staying on Top of Accreditation & Regulatory Surveys

It’s essential for providers to be ready at any time for surveyors, especially now that the new USP 800 hazardous drugs regulations are in effect.

Read more


    Premier's Alkire on Drug Shortages

Premier’s Alkire on Drug Shortages

Bloomberg | Michael Alkire, President of Premier Inc., talks about drug shortages with Lisa Abramowicz and Paul Sweeney. Full Podcast

Read more


    InsightRX and Premier Inc. Partner to Enable Hospitals, Health Systems and Providers to Individualize Treatment for Infectious Disease Patients

InsightRX and Premier Inc. Partner to Enable Hospitals, Health Systems and Providers to Individualize Treatment for Infectious Disease Patients

InsightRx | Integrated solution aims to decrease serious side effects caused by vancomycin and other antibiotics used to treat infectious diseases

Read more


    Premier Joins 47 Organizations in Supporting the Mitigating Emergency Drug Shortages (MEDS) Act

Premier Joins 47 Organizations in Supporting the Mitigating Emergency Drug Shortages (MEDS) Act

Premier and 47 national trade associations, health systems and hospitals, pharmacy associations, and small businesses voiced support for the MEDS Act.

Read more


    Statement on the Introduction of the Mitigating Emergency Drug Shortages Act

Statement on the Introduction of the Mitigating Emergency Drug Shortages Act

Premier strongly supports the MEDS Act (S. 2723), introduced today by Senators Susan Collins (R-ME) and Tina Smith (D-MN).

Read more


    What We’re Watching: October 29, 2019

What We’re Watching: October 29, 2019

We hear that major legislation may be introduced this week to address drug shortages.

Read more


    Statement on the FDA Drug Shortage Task Force Report

Statement on the FDA Drug Shortage Task Force Report

Premier Statement on the FDA Drug Shortage Task Force report.

Read more


    What We’re Watching: October 15, 2019

What We’re Watching: October 15, 2019

Thanks to ProvideGx, the multi-year, national shortage of cysteine hydrochloride injection has been successfully resolved​.

Read more


    Premier Cautions DEA on Proposal to Reduce CII Quotas in 2020

Premier Cautions DEA on Proposal to Reduce CII Quotas in 2020

Premier submitted comments cautioning the DEA to carefully consider how a reduction in manufacturing quotas for certain opioids could rekindle recent drug shortages.

Read more


    Premier’s ProvideGx™ Program Partners with Amphastar to Provide Seven Shortage Drugs, Most in Emergency, Pre-Filled Syringes

Premier’s ProvideGx™ Program Partners with Amphastar to Provide Seven Shortage Drugs, Most in Emergency, Pre-Filled Syringes

Through its ProvideGx™ program, Premier has partnered with Amphastar Pharmaceuticals, Inc. to supply to healthcare providers phytonadione injection and emergency, pre-filled syringes.

Read more


    Partnership Between Premier’s ProvideGx™ Program and Exela Pharma Sciences, LLC, Successfully Resolves National Shortage of Cysteine Hydrochloride

Partnership Between Premier’s ProvideGx™ Program and Exela Pharma Sciences, LLC, Successfully Resolves National Shortage of Cysteine Hydrochloride

Premier's ProvideGx™ program and its partnership with Exela Pharma Sciences has successfully resolved the multi-year, national shortage of cysteine hydrochloride injection.

Read more


    InsightRX Raises $10 Million To Personalize Drug Doses

InsightRX Raises $10 Million To Personalize Drug Doses

Forbes | InsightRx, a precision medicine company announced the closing of funding with participation from several organizations including Premier.

Read more


    Premier Statement on FDA Action to Address the Use of Citizen Petitions to Delay Market Competition of Generics and Biosimilars

Premier Statement on FDA Action to Address the Use of Citizen Petitions to Delay Market Competition of Generics and Biosimilars

Members of Premier applaud the FDA for finalizing guidance on the use of citizen petitions to delay the market entry of generic medications and biosimilars.

Read more


    Premier Comments on CMS Proposed Requirements for Long-Term Care Facilities

Premier Comments on CMS Proposed Requirements for Long-Term Care Facilities

Premier submitted comments to CMS on its proposed rule aiming to reduce burden and redundant requirements in long-term care facilities (LTCFs). In its comments...

Read more


    Premier Inc. Projects 4.2 Percent Price Inflation for Pharmaceuticals

Premier Inc. Projects 4.2 Percent Price Inflation for Pharmaceuticals

Prices projected to increase over previous estimates, driven by newly released products such as cellular and gene therapies.

Read more


    Premier Comments on Home Infusion Payment and Quality Reporting Policies in CY 2020 Home Health Proposed Rule

Premier Comments on Home Infusion Payment and Quality Reporting Policies in CY 2020 Home Health Proposed Rule

Premier continues to urge CMS to amend its misguided policy for Medicare coverage of home infusion therapy services.

Read more


    Presidential Candidates Aren’t Talking About Drug Shortages. They Should Be

Presidential Candidates Aren’t Talking About Drug Shortages. They Should Be

STAT | A similar company launched in January 2019: ProvideGx, founded by Premier, a health care improvement company with 4,000 allied hospitals.Full story

Read more


    What We're Watching: August 6, 2019

What We’re Watching: August 6, 2019

CMS released the proposed OPPS rule. We're opposed to the posting of negotiated rates, site neutral payments and continuation of the 340B cuts.

Read more


    How Our Health Systems Are Working to Prevent Hospital Drug Shortages

How Our Health Systems Are Working to Prevent Hospital Drug Shortages

STAT | Premier members discuss how their health systems are working to prevent hospital drug shortages.

Read more


    Statement on the CY 2020 OPPS Proposed Rule

Statement on the CY 2020 OPPS Proposed Rule

Premier opposes CMS’ continuation of Medicare site-neutral payments that will reduce payment for outpatient clinic visits by 60 percent.

Read more

Login Register Change Registration